Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently. [electronic resource]
Producer: 20140926Description: 263-9 p. digitalISSN:- 1532-7361
- Antineoplastic Agents -- pharmacology
- Carcinoma, Hepatocellular -- drug therapy
- Cell Death -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm
- Genetic Engineering
- Humans
- Liver Neoplasms -- drug therapy
- Niacinamide -- analogs & derivatives
- Oncolytic Virotherapy -- methods
- Phenylurea Compounds -- pharmacology
- Sorafenib
- Vaccinia virus -- genetics
- Viral Plaque Assay
- Virus Replication
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.